The broadly neutralizing antibodies, potently neutralizing the SARS-CoV-2 Omicron subvariants BA.5/BA.4/BA.3/BA.2 /BA.1 are in stock.
BA.2 ,BA.3,BA.4/BA.5 Spike RBD bind with different antibodies
Fig1.SARA-CoV-2(BA.2)spike RBD binds with different antibodies
Fig2.SARA-CoV-2(BA.3)spike RBD binds with different antibodies
Fig3.SARA-CoV-2(BA.4/BA.5)spike RBD binds with different antibodies
Product List:
Antibodies
Product name |
Catalog |
Research Grade Amubarvimab | |
Anti-SARS2 RBD Antibody(S2H97) | |
Anti-SARS2 RBD Antibody(S2E12) | |
Research Grade Sotrovimab | |
Research Grade Cilgavimab | |
Research Grade DXP-604 | |
Research Grade Romlusevimab | |
Research Grade Bebtelovimab | |
Research Grade Adintrevimab | |
Research Grade Anti-SARS-CoV-2 RBD (6M6) | |
Research Grade Anti-SARS-CoV-2 RBD (COV44-62) | |
Research Grade Anti-SARS-CoV-2 RBD (COV44-79) | |
Research Grade Anti-SARS-CoV-2 RBD (ADI-62113) | |
Research Grade Anti-SARS-CoV-2 RBD (Beta-27 Fab) | |
Research Grade Anti-SARS-CoV-2 RBD (C1) |
*All products are for research use only. Not for human or drug use.
Recombinant antigens
Product name |
Catalog |
Recombinant SARS-CoV-2 RBD(Omicron/B.1.1.529) Protein, C-His | |
Recombinant SARS-CoV-2 RBD(Omicron/BA.2) Protein, C-His | |
Recombinant SARS-CoV-2 RBD(Omicron_BA.3) Protein, C-His | |
Recombinant SARS-CoV-2 RBD(Omicron/BA.4) Protein, C-His | |
Recombinant SARS-CoV-2 RBD(Omicron/BA.5) Protein, C-His |
*All products are for research use only. Not for human or drug use.
References:
1.Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. PMID: 35016195
2.Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination. PMID: 35478188
3.BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. PMID: 35714668
4.Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody. PMID: 35344711
5.Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. PMID: 35076256